AI in Pharmaceuticals: From Discovery to Market
Complex Discovery
OCTOBER 19, 2024
Editor’s Note: Artificial intelligence (AI) is transforming the pharmaceutical industry, offering unprecedented opportunities to accelerate drug discovery, streamline clinical trials, and fortify intellectual property (IP) strategies. Maintaining a clear chain of custody for AI-involved processes becomes crucial.
Let's personalize your content